1. The effect of granulocyte-colony-stimulating factors on survival parameters in pediatric patients with acute lymphoblastic leukemia: a retrospective study;Tekgunduz;Transf Aph Sci,2022
2. Severe congenital neutropenia, a genetically heterogenous disease group with an increased risk of AML/MDS;Vandenberghe;Pediatr Rep,2011
3. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma;Calip;Cancer,2019
4. Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer;Calip;Breast Cancer Res Treat,2015
5. Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01;Lohmann;Pedia Blood Cancer,2019